The aP-based vaccines contain up to five pertussis antigens including pertactin (PRN), filamentous hemagglutinin adhesin (FHA), fimbriae 2 and 3 (FIM), and pertussis toxoid (PT). This evidence concerns the gene ZMYM2 and pertussis.